Mercury Laboratories Limited (MERCURYLAB.BO)
INR 854.9
(4.09%)
INR 854.9
(4.09%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 755.59 Million INR | 0.3% |
| 2022 | 753.33 Million INR | 30.06% |
| 2021 | 579.23 Million INR | -15.56% |
| 2020 | 686.01 Million INR | 19.79% |
| 2019 | 572.69 Million INR | 3.18% |
| 2018 | 555.04 Million INR | 7.01% |
| 2017 | 518.67 Million INR | 8.0% |
| 2016 | 480.27 Million INR | 1.07% |
| 2015 | 475.17 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 166.76 Million INR | -3.98% |
| 2023 Q2 | 227.55 Million INR | 24.2% |
| 2023 Q1 | 183.22 Million INR | -5.71% |
| 2023 Q3 | 171.14 Million INR | -24.79% |
| 2023 FY | 755.59 Million INR | 0.3% |
| 2023 Q4 | 173.67 Million INR | 1.48% |
| 2022 FY | 753.33 Million INR | 30.06% |
| 2022 Q1 | 175.99 Million INR | 32.0% |
| 2022 Q4 | 194.31 Million INR | 19.72% |
| 2022 Q3 | 162.31 Million INR | -26.46% |
| 2022 Q2 | 220.72 Million INR | 25.42% |
| 2021 Q1 | 155.23 Million INR | -12.7% |
| 2021 Q2 | 134.72 Million INR | -13.21% |
| 2021 FY | 579.23 Million INR | -15.56% |
| 2021 Q3 | 155.95 Million INR | 15.75% |
| 2021 Q4 | 133.32 Million INR | -14.51% |
| 2020 FY | 686.01 Million INR | 19.79% |
| 2020 Q3 | 185.54 Million INR | -1.88% |
| 2020 Q1 | 133.54 Million INR | 13.43% |
| 2020 Q4 | 177.82 Million INR | -4.16% |
| 2020 Q2 | 189.1 Million INR | 41.61% |
| 2019 Q1 | 147.51 Million INR | 22.17% |
| 2019 FY | 572.69 Million INR | 3.18% |
| 2019 Q4 | 117.72 Million INR | -24.41% |
| 2019 Q3 | 155.73 Million INR | 2.65% |
| 2019 Q2 | 151.71 Million INR | 2.85% |
| 2018 FY | 555.04 Million INR | 7.01% |
| 2018 Q4 | 120.74 Million INR | -31.12% |
| 2018 Q1 | 130.34 Million INR | 1.52% |
| 2018 Q2 | 128.81 Million INR | -1.17% |
| 2018 Q3 | 175.29 Million INR | 36.08% |
| 2017 Q1 | 106.5 Million INR | -18.08% |
| 2017 FY | 518.67 Million INR | 8.0% |
| 2017 Q4 | 128.39 Million INR | -7.3% |
| 2017 Q3 | 138.5 Million INR | -4.66% |
| 2017 Q2 | 145.27 Million INR | 36.4% |
| 2016 Q2 | 116.15 Million INR | -9.96% |
| 2016 Q1 | 129 Million INR | 31.65% |
| 2016 FY | 480.27 Million INR | 1.07% |
| 2016 Q3 | 105.42 Million INR | -9.24% |
| 2016 Q4 | 130.01 Million INR | 23.33% |
| 2015 Q1 | 129 Million INR | 53.18% |
| 2015 Q2 | 122.45 Million INR | -5.08% |
| 2015 FY | 475.17 Million INR | 0.0% |
| 2015 Q4 | 97.99 Million INR | -22.06% |
| 2015 Q3 | 125.72 Million INR | 2.67% |
| 2014 Q4 | 84.21 Million INR | -12.74% |
| 2014 Q1 | 107.53 Million INR | 0.0% |
| 2014 Q3 | 96.51 Million INR | -21.94% |
| 2014 Q2 | 123.64 Million INR | 14.98% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| ANG Lifesciences India Limited | 1.46 Billion INR | 48.286% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 62.61% |
| Bacil Pharma Limited | - INR | -Infinity% |
| Beryl Drugs Limited | 271.24 Million INR | -178.562% |
| Cian Healthcare Limited | 616.95 Million INR | -22.471% |
| Colinz Laboratories Limited | 70.29 Million INR | -974.869% |
| Concord Drugs Limited | 449.24 Million INR | -68.191% |
| Deccan Health Care Limited | 597.28 Million INR | -26.503% |
| Gennex Laboratories Limited | 867.14 Million INR | 12.865% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | -57.498% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -397.505% |
| Kerala Ayurveda Limited | 1.02 Billion INR | 26.166% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 75.402% |
| Panchsheel Organics Limited | 1.05 Billion INR | 28.189% |
| Parmax Pharma Limited | 154.24 Million INR | -389.868% |
| Parnax Lab Limited | 1.88 Billion INR | 59.961% |
| Patidar Buildcon Limited | 2.3 Million INR | -32637.868% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -399.99% |
| Phaarmasia Limited | 305.93 Million INR | -146.979% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | -12.304% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 94.428% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | -88.789% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | -176.805% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 83.7% |
| Sunil Healthcare Limited | 901.91 Million INR | 16.224% |
| Syschem (India) Limited | 2.33 Billion INR | 67.645% |
| Trident Lifeline Limited | 446.28 Million INR | -69.306% |
| Transchem Limited | 4.09 Million INR | -18329.029% |
| Tyche Industries Limited | 696.83 Million INR | -8.431% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | 39.751% |
| Vasundhara Rasayans Limited | 370.18 Million INR | -104.112% |
| Zenith Healthcare Limited | 144.71 Million INR | -422.116% |
| Zenotech Laboratories Limited | 368.08 Million INR | -105.274% |
| Hindustan Bio Sciences Limited | 10.48 Million INR | -7103.275% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 27.954% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -4010.489% |
| MedPlus Health Services Limited | 56.24 Billion INR | 98.657% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | -40.739% |
| Smruthi Organics Limited | 1.27 Billion INR | 40.804% |
| Trimurthi Limited | 42.23 Million INR | -1688.887% |
| Zenlabs Ethica Limited | 585.63 Million INR | -29.022% |
| Makers Laboratories Limited | 1.03 Billion INR | 27.181% |
| Lactose (India) Limited | 1.13 Billion INR | 33.656% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | -69.38% |
| Roopa Industries Limited | 715.53 Million INR | -5.598% |
| PANJON LTD. | 125.52 Million INR | -501.963% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 88.322% |
| Crestchem Limited | 212.56 Million INR | -255.468% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -13509.33% |
| PRAVEG LIMITED | 915.96 Million INR | 17.509% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 78.297% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | -1.322% |
| Norris Medicines Limited | 56.35 Million INR | -1240.741% |
| Denis Chem Lab Limited | 1.67 Billion INR | 54.977% |
| Veerhealth Care Limited | 142.13 Million INR | -431.604% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 46.777% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | -90.603% |
| Godavari Drugs Limited | 1.56 Billion INR | 51.785% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -67484.079% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 56.657% |
| Vivanza Biosciences Limited | 278.89 Million INR | -170.926% |
| Medi-Caps Limited | 265.63 Million INR | -184.447% |
| DECIPHER LABS LIMITED | 362.75 Million INR | -108.293% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | 39.983% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 55.507% |
| Bharat Parenterals Limited | 2.59 Billion INR | 70.873% |
| BDH Industries Limited | 858.31 Million INR | 11.968% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -634.452% |
| Coral Laboratories Limited | 836.6 Million INR | 9.684% |
| Evoq Remedies Limited | 63.09 Million INR | -1097.638% |
| Trinity League India Limited | 2.95 Million INR | -25513.22% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 51.384% |
| Auro Laboratories Limited | 526.99 Million INR | -43.377% |